205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.76%
Both yoy net incomes decline, with MRVL at -27.12%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-1.67%
Negative yoy D&A while MRVL is 8.83%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
73.33%
Well above MRVL's 100.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-7.04%
Negative yoy SBC while MRVL is 20.12%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
242.42%
Less working capital growth vs. MRVL's 10217.21%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
1160.00%
AR growth well above MRVL's 178.29%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
16.67%
Inventory shrinking or stable vs. MRVL's 240.11%, indicating lean supply management. David Dodd would confirm no demand shortfall.
176.47%
AP growth well above MRVL's 105.18%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-91.45%
Both reduce yoy usage, with MRVL at -337.32%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-390.91%
Both negative yoy, with MRVL at -99.63%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
4.17%
Operating cash flow growth below 50% of MRVL's 49.80%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
13.71%
Some CapEx rise while MRVL is negative at -84.02%. John Neff would see competitor possibly building capacity while we hold back expansions.
-13.71%
Negative yoy acquisition while MRVL stands at 2531.50%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
5.81%
Less growth in investment purchases vs. MRVL's 38.84%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
0.15%
Below 50% of MRVL's 18.67%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
35.54%
Less 'other investing' outflow yoy vs. MRVL's 80.89%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
41.98%
Lower net investing outflow yoy vs. MRVL's 190.69%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-51.86%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.